What specific change did RBC Capital make to its price target and rating for DuPont de Nemours, and how does this compare to UBS's recent action?

RBC Capital adjusted its price target for DuPont de Nemours (DD) to $176 from $180 while maintaining its 'Outperform' rating; this update coincided with UBS revising its own price target to $178 from $175 and keeping a 'Buy' rating.

What recent financial performance or guidance update by DuPont de Nemours prompted RBC Capital’s price target adjustment?

The adjustment followed DuPont de Nemours’ Q2 2026 earnings report, which showed increases in both adjusted earnings and revenue, and included an update to its full-year 2026 guidance.

RBC Capital Adjusts PT on DuPont de Nemours to $176 From $180, Maintains Outperform Rating

Aug 7, 2026

RBC Capital lowered DuPont de Nemours' price target to $176 while maintaining an Outperform rating after Q2 2026 earnings showed revenue and earnings growth with updated guidance.

marketscreener.com

2026-04-21

UBS Raises Corteva Price Target to $88, Maintains Neutral Rating

2026-04-22

DuPont de Nemours Inc. Stock Underperforms vs Competitors on Wednesday

2026-04-24

DuPont’s Electronics Spinoff Qnity Prices $4.1B Debt Deal Ahead of November Split

2026-04-24

RBC Adjusts Price Target on DuPont de Nemours to $56 From $60, Maintains Outperform Rating

2026-04-28

Morgan Stanley Adjusts DuPont de Nemours Price Target to $52 From $44, Maintains Equal Weight Rating